Faxén UL, Hage C, Andreasson A, Donal E, Daubert JC, Linde C, Brismar K, Lund LH (2017) HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin. Int J Cardiol 228:709–716. https://doi.org/10.1016/j.ijcard.2016.11.194

Article  PubMed  Google Scholar 

Theodorakis N, Kreouzi M, Hitas C, Anagnostou D, Nikolaou M (2024) Adipokines and cardiometabolic heart failure with preserved ejection fraction: a state-of-the-art review. Diagnostics 14:2677. https://doi.org/10.3390/diagnostics14232677

Article  PubMed  PubMed Central  CAS  Google Scholar 

Poetsch MS, Strano A, Guan K (2020) Role of leptin in cardiovascular diseases. Front Endocrinol (Lausanne) 11:354. https://doi.org/10.3389/fendo.2020.00354

Article  PubMed  Google Scholar 

Evans MC, Lord RA, Anderson GM (2021) Multiple leptin signaling pathways in the control of metabolism and fertility: a means to different ends? Int J Mol Sci 22:9210. https://doi.org/10.3390/ijms22179210

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mark AL (2013) Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol 305:R566–R581. https://doi.org/10.1152/ajpregu.00180.2013

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bai W, Huang J, Zhu M, Liu X, Tao J (2019) Association between elevated adiponectin level and adverse outcomes in patients with heart failure: a systematic review and meta-analysis. Braz J Med Biol Res 52:e8416. https://doi.org/10.1590/1414-431X20198416

Article  PubMed  PubMed Central  Google Scholar 

Mayer O Jr, Bruthans J, Seidlerová J et al (2022) High leptin status indicates an increased risk of mortality and heart failure in stable coronary artery disease. Nutr Metab Cardiovasc Dis 32(9):2137–2146. https://doi.org/10.1016/j.numecd.2022.06.006

Article  PubMed  CAS  Google Scholar 

Lieb W, Sullivan LM, Harris TB et al (2009) Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Diabetes Care 32(4):612–616. https://doi.org/10.2337/dc08-1596

Article  PubMed  CAS  Google Scholar 

Dinh Cat AN, Friederich-Persson M, White A, Touyz RM (2016) Adipocytes, aldosterone and obesity-related hypertension. J Mol Endocrinol 57:F7–F21. https://doi.org/10.1530/JME-16-0025

Article  PubMed  CAS  Google Scholar 

Bachmann KN, Gupta DK, Xu M, Brittain E, Farber-Eger E, Arora P, Collins S, Wells QS, Wang TJ (2021) Unexpectedly low natriuretic peptide levels in patients with heart failure. JACC Heart Fail 9:192–200. https://doi.org/10.1016/j.jchf.2020.10.008

Article  PubMed  PubMed Central  Google Scholar 

Packer M (2018) Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity. Circulation 137:1614–1631. https://doi.org/10.1161/CIRCULATIONAHA.117.032474

Article  PubMed  CAS  Google Scholar 

Faulkner JL, Bruder-Nascimento T, Belin de Chantemèle EJ (2018) The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease. Curr Opin Nephrol Hypertens 27:63–69. https://doi.org/10.1097/MNH.0000000000000384

Article  PubMed  PubMed Central  CAS  Google Scholar 

Standeven KF, Hess K, Carter AM, Rice GI, Cordell PA, Balmforth AJ, Lu B, Scott DJ, Turner AJ, Hooper NM, Grant PJ (2011) Neprilysin, obesity and the metabolic syndrome. Int J Obes (Lond) 35:1031–1040. https://doi.org/10.1038/ijo.2010.227

Article  PubMed  CAS  Google Scholar 

Pascual-Figal DA (2017) Neprilysin and heart failure: a “sympathetic” relationship? J Am Coll Cardiol 70:2154–2156. https://doi.org/10.1016/j.jacc.2017.09.003

Article  PubMed  Google Scholar 

Mann DL, Felker GM (2021) Mechanisms and models in heart failure: a translational approach. Circ Res 128:1435–1450. https://doi.org/10.1161/CIRCRESAHA.121.318158

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pérez-Pérez A, Sánchez-Jiménez F, Vilariño-García T, Sánchez-Margalet V (2020) Role of leptin in inflammation and vice versa. Int J Mol Sci 21:5887. https://doi.org/10.3390/ijms21165887

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chiu CZ, Wang BW, Shyu KG (2015) Molecular regulation of the expression of leptin by hypoxia in human coronary artery smooth muscle cells. J Biomed Sci 22:5. https://doi.org/10.1186/s12929-014-0109-8

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rausch LK, Hofer M, Pramsohler S, Kaser S, Ebenbichler C, Haacke S, Gatterer H, Netzer NC (2018) Adiponectin, leptin and visfatin in hypoxia and its effect for weight loss in obesity. Front Endocrinol (Lausanne) 9:615. https://doi.org/10.3389/fendo.2018.00615

Article  PubMed  Google Scholar 

Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, Lingvay I, Colhoun HM, Plutzky J, Kosiborod MN et al (2024) Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. Lancet 404:773–786. https://doi.org/10.1016/S0140-6736(24)01498-3

Article  PubMed  CAS  Google Scholar 

Theodorakis N, Nikolaou M (2025) Integrated management of cardiovascular-renal-hepatic-metabolic syndrome: expanding roles of SGLT2is, GLP-1RAs, and GIP/GLP-1RAs. Biomedicines 13(1):135. https://doi.org/10.3390/biomedicines13010135

Article  PubMed  PubMed Central  CAS  Google Scholar 

Packer M (2018) Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis. Diabetes Obes Metab 20:1361–1366. https://doi.org/10.1111/dom.13229

Article  PubMed  CAS  Google Scholar 

Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M et al (2024) Finerenone in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 391:1475–1485. https://doi.org/10.1056/NEJMoa2407107

Article  PubMed  CAS  Google Scholar 

Zhao S, Kusminski CM, Scherer PE (2021) Adiponectin, leptin, and cardiovascular disorders. Circ Res 128(1):136–149. https://doi.org/10.1161/CIRCRESAHA.120.314458

Article  PubMed  PubMed Central  CAS  Google Scholar 

Packer M (2018) Derangements in adrenergic-adipokine signaling establish a neurohormonal basis for obesity-related heart failure with a preserved ejection fraction. Eur J Heart Fail 20:873–878. https://doi.org/10.1002/ejhf.1136

Article  PubMed  CAS  Google Scholar 

Chiu CZ, Wang BW, Shyu KG (2015) Molecular regulation of the expression of leptin by hypoxia in human coronary artery smooth muscle cells. J Biomed Sci 22:5. https://doi.org/10.1186/s12929-015-0112-8

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rausch LK, Hofer M, Pramsohler S et al (2018) Adiponectin, leptin, and visfatin in hypoxia and its effect on weight loss in obesity. Front Endocrinol 9:615. https://doi.org/10.3389/fendo.2018.00615

Article  Google Scholar 

Cittadini A, Salzano A, Iacoviello M, Triggiani V, Rengo G, Cacciatore F, Maiello C, Limongelli G, Masarone D, Perticone F, Cimellaro A, Perrone Filardi P, Paolillo S, Mancini A, Volterrani M, Vriz O, Castello R, Passantino A, Campo M, Modesti PA, De Giorgi A, Monte IP, Puzzo A, Ballotta A, D’Assante R, Arcopinto M, Gargiulo P, Sciacqua A, Bruzzese D, Colao A, Napoli R, Suzuki T, Eagle KA, Ventura HO, Marra AM, Bossone E (2021) Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry Eur J Prev Cardiol 28:1691–1700. https://doi.org/10.1093/eurjpc/zwab020

Article  PubMed